Corcept Therapeutics Incorporated
Q4 2021 Earnings Call Transcript

Published:

  • Disclaimer*:
    This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.
  • Operator:
    00
  • Atabak Mokari:
    00
  • Charlie Robb:
    02
  • Joseph Belanoff:
    05
  • Operator:
    24
  • Matt Kaplan:
    24
  • Charlie Robb:
    24
  • Matt Kaplan:
    25
  • Joseph Belanoff:
    25
  • Bill Guyer:
    25
  • Matt Kaplan:
    26
  • Joseph Belanoff:
    27
  • Operator:
    27
  • Chris Howerton:
    27
  • Joseph Belanoff:
    28
  • Bill Guyer:
    28
  • Joseph Belanoff:
    28
  • Sean Maduck:
    29
  • Chris Howerton:
    30
  • Joseph Belanoff:
    30
  • Chris Howerton:
    30
  • Joseph Belanoff:
    31
  • Chris Howerton:
    33
  • Joseph Belanoff:
    33
  • Operator:
    33
  • Greg Fraser:
    33
  • Joseph Belanoff:
    33
  • Sean Maduck:
    33
  • Greg Fraser:
    34
  • Joseph Belanoff:
    35
  • Greg Fraser:
    35
  • Joseph Belanoff:
    35
  • Greg Fraser:
    36
  • Operator:
    36
  • Tazeen Ahmad:
    36
  • Joseph Belanoff:
    37
  • Bill Guyer:
    40
  • Tazeen Ahmad:
    41
  • Bill Guyer:
    41
  • Tazeen Ahmad:
    41
  • Joseph Belanoff:
    41
  • Operator:
    41
  • Michelle Gilson:
    41
  • Joseph Belanoff:
    42
  • Sean Maduck:
    42
  • Michelle Gilson:
    44
  • Joseph Belanoff:
    45
  • Michelle Gilson:
    47
  • Joseph Belanoff:
    48
  • Michelle Gilson:
    48
  • Joseph Belanoff:
    48
  • Operator:
    Thank you. Our next question comes from Arthur He with H.C. Wainwright. You may proceed with your question.
  • Arthur He:
    48
  • Joseph Belanoff:
    48
  • Bill Guyer:
    48
  • Joseph Belanoff:
    49
  • Arthur He:
    50
  • Joseph Belanoff:
    50
  • Arthur He:
    50
  • Joseph Belanoff:
    51
  • Arthur He:
    52
  • Operator:
    52
  • Greg Fraser:
    52
  • Joseph Belanoff:
    52
  • Greg Fraser:
    55
  • Joseph Belanoff:
    Thanks for all those who tuned in. Thank you very much. We'll talk to you in another quarter. This is really a very exciting year for Corcept. I really -- if you're just being introduced to the company, this is a good time to take a serious look. We'll talk to you in another quarter. Thank you very much. And have a good rest of the day.
  • Operator:
    55

Other Corcept Therapeutics Incorporated earnings call transcripts: